MedPath

Fenretinide

Generic Name
Fenretinide
Drug Type
Small Molecule
Chemical Formula
C26H33NO2
CAS Number
65646-68-6
Unique Ingredient Identifier
187EJ7QEXL

Overview

A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.

Background

A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.

Indication

Investigated for use/treatment in macular degeneration.

Associated Conditions

No associated conditions information available.

Clinical Trials

Phase 1
Not yet recruiting
Posted: 2025/04/10
Sponsor:
SciTech Development,...
Phase 2
Active, not recruiting
Posted: 2024/07/30
Sponsor:
Island Pharmaceutica...
Phase 1
Completed
Posted: 2023/12/26
Sponsor:
Island Pharmaceutica...

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath